Diabetic cardiomyopathy: Pathophysiological and clinical aspects

P. Gargiulo, Gianluca Iacobellis, V. Vaccari, D. Andreani

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Several studies have suggested the existence of a diabetic cardiomyopathy independent of coronary vascular sclerosis and hypertension. The condition is often without symptoms and/or with slight signs of anatomical and functional abnormalities. The pathogenetic mechanisms involved are various and not all completely understood. Metabolic abnormalities in glucose transport and lipid metabolism alterated calcium and potassium homeostasis, microangiopathy with microaneurisms and microthrombi, cardiomyocytes hyperthrophy, structural collagen alterations, interstitial and perivascular fibrosis and deficit in serin-protease inhibitors have been described as frequent and partly specific features of diabetic cardiomyopathy. Echocardiography has demonstrated the presence of a diastolic dysfunction, as the earliest sign of diabetic cardiomyopathy. Slight left ventricular hypertrophy with impaired left ventricular filling and relaxation has been described. Systolic function is normal or even increased at rest, but usually decreased during heavy exercise. In conclusion, according to these findings, diabetic cardiomyopathy seems to be a rather early complication, although frequently latent, but independent of other clinical conditions involving the heart in diabetes.

Original languageEnglish (US)
Pages (from-to)336-346
Number of pages11
JournalDiabetes, Nutrition and Metabolism - Clinical and Experimental
Volume11
Issue number6
StatePublished - 1998
Externally publishedYes

Fingerprint

Diabetic Cardiomyopathies
cardiomyopathy
microangiopathy
echocardiography
sclerosis
Left Ventricular Hypertrophy
proteinase inhibitors
Protease Inhibitors
fibrosis
hypertrophy
Lipid Metabolism
Cardiac Myocytes
blood vessels
lipid metabolism
hypertension
signs and symptoms (animals and humans)
diabetes
Echocardiography
collagen
Coronary Artery Disease

Keywords

  • Cardiomyopathy
  • Diabetes mellitus
  • Diabetic myocytes damage
  • Diastolic dysfunction
  • Systolic dysfunction

ASJC Scopus subject areas

  • Food Science
  • Endocrinology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Diabetic cardiomyopathy : Pathophysiological and clinical aspects. / Gargiulo, P.; Iacobellis, Gianluca; Vaccari, V.; Andreani, D.

In: Diabetes, Nutrition and Metabolism - Clinical and Experimental, Vol. 11, No. 6, 1998, p. 336-346.

Research output: Contribution to journalArticle

@article{9894db1eab11463ba15bcc21b116d05c,
title = "Diabetic cardiomyopathy: Pathophysiological and clinical aspects",
abstract = "Several studies have suggested the existence of a diabetic cardiomyopathy independent of coronary vascular sclerosis and hypertension. The condition is often without symptoms and/or with slight signs of anatomical and functional abnormalities. The pathogenetic mechanisms involved are various and not all completely understood. Metabolic abnormalities in glucose transport and lipid metabolism alterated calcium and potassium homeostasis, microangiopathy with microaneurisms and microthrombi, cardiomyocytes hyperthrophy, structural collagen alterations, interstitial and perivascular fibrosis and deficit in serin-protease inhibitors have been described as frequent and partly specific features of diabetic cardiomyopathy. Echocardiography has demonstrated the presence of a diastolic dysfunction, as the earliest sign of diabetic cardiomyopathy. Slight left ventricular hypertrophy with impaired left ventricular filling and relaxation has been described. Systolic function is normal or even increased at rest, but usually decreased during heavy exercise. In conclusion, according to these findings, diabetic cardiomyopathy seems to be a rather early complication, although frequently latent, but independent of other clinical conditions involving the heart in diabetes.",
keywords = "Cardiomyopathy, Diabetes mellitus, Diabetic myocytes damage, Diastolic dysfunction, Systolic dysfunction",
author = "P. Gargiulo and Gianluca Iacobellis and V. Vaccari and D. Andreani",
year = "1998",
language = "English (US)",
volume = "11",
pages = "336--346",
journal = "Diabetes, Nutrition and Metabolism - Clinical and Experimental",
issn = "0394-3402",
publisher = "Editrice Kurtis s.r.l.",
number = "6",

}

TY - JOUR

T1 - Diabetic cardiomyopathy

T2 - Pathophysiological and clinical aspects

AU - Gargiulo, P.

AU - Iacobellis, Gianluca

AU - Vaccari, V.

AU - Andreani, D.

PY - 1998

Y1 - 1998

N2 - Several studies have suggested the existence of a diabetic cardiomyopathy independent of coronary vascular sclerosis and hypertension. The condition is often without symptoms and/or with slight signs of anatomical and functional abnormalities. The pathogenetic mechanisms involved are various and not all completely understood. Metabolic abnormalities in glucose transport and lipid metabolism alterated calcium and potassium homeostasis, microangiopathy with microaneurisms and microthrombi, cardiomyocytes hyperthrophy, structural collagen alterations, interstitial and perivascular fibrosis and deficit in serin-protease inhibitors have been described as frequent and partly specific features of diabetic cardiomyopathy. Echocardiography has demonstrated the presence of a diastolic dysfunction, as the earliest sign of diabetic cardiomyopathy. Slight left ventricular hypertrophy with impaired left ventricular filling and relaxation has been described. Systolic function is normal or even increased at rest, but usually decreased during heavy exercise. In conclusion, according to these findings, diabetic cardiomyopathy seems to be a rather early complication, although frequently latent, but independent of other clinical conditions involving the heart in diabetes.

AB - Several studies have suggested the existence of a diabetic cardiomyopathy independent of coronary vascular sclerosis and hypertension. The condition is often without symptoms and/or with slight signs of anatomical and functional abnormalities. The pathogenetic mechanisms involved are various and not all completely understood. Metabolic abnormalities in glucose transport and lipid metabolism alterated calcium and potassium homeostasis, microangiopathy with microaneurisms and microthrombi, cardiomyocytes hyperthrophy, structural collagen alterations, interstitial and perivascular fibrosis and deficit in serin-protease inhibitors have been described as frequent and partly specific features of diabetic cardiomyopathy. Echocardiography has demonstrated the presence of a diastolic dysfunction, as the earliest sign of diabetic cardiomyopathy. Slight left ventricular hypertrophy with impaired left ventricular filling and relaxation has been described. Systolic function is normal or even increased at rest, but usually decreased during heavy exercise. In conclusion, according to these findings, diabetic cardiomyopathy seems to be a rather early complication, although frequently latent, but independent of other clinical conditions involving the heart in diabetes.

KW - Cardiomyopathy

KW - Diabetes mellitus

KW - Diabetic myocytes damage

KW - Diastolic dysfunction

KW - Systolic dysfunction

UR - http://www.scopus.com/inward/record.url?scp=0032468531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032468531&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032468531

VL - 11

SP - 336

EP - 346

JO - Diabetes, Nutrition and Metabolism - Clinical and Experimental

JF - Diabetes, Nutrition and Metabolism - Clinical and Experimental

SN - 0394-3402

IS - 6

ER -